Get Answers on Test Preparation, Admissions & Campus Life
Study Abroad Countries
What should I prefer between AIIMS Delhi and NIMHANS for an MD in psychiatry?
AIIMS Delhi and NIMHANS Bangalore are both prominent medical institutes, being ranked 1st and 4th, respectively in India in the medical category by NIRF 2023. Both the institutes are equally good for MD, however, for an MD in Psychiatry, NIMHANS is considered to be a better option than AIIMS Delhi.
One must prioritize the branch over the college in case of their degree, especially in medicine. One should look after the other aspects such as the course faculty, facilities provided for the course, and lastly the clinical experience and exposure. NIMHANS is renowned all over India for its excellence in Psychiatry and is one of the top institutions for mental health and neuroscience education. Since NIMHANS specializes in Neurosciences, it is claimed to have a stronger focus and approach towards specialized learning and training in Psychiatry than AIIMS Delhi.
Through AIIMS Delhi is the most popular choice for every medical aspirant, but for MD in Psychiatry is indeed the best option given the knowledge, skills, and clinical experience it has to share for courses in Mental Health. Admission to MD in Psychiatry at both AIIMS Delhi and NIMHANS is based on the score in INI CET.
What are the pros and cons of doing an MD in psychiatry at KGMU or CIP in Ranchi?
I can shed some light on the Psychiatry department of CIP Ranchi.
I don’t have much information about KGMU. But as far as CIP Ranchi is considered, the only academic pro is its enormous patient load. This offers a great exposure. Other than that, you’ll meet good peers and seniors. The biggest con, on the other hand, is the anti research attitude. People aren’t encouraged towards research. Only after you start publishing papers, do others invite you to their work.
But also, a lot has changed at CIP Ranchi in the past years. So I recommend you approach some seniors from both the colleges before arriving at a decision.
SUBSCRIBE TO OUR NEWS LETTER
